Maiwald’s work spans the full patent lifecycle, from drafting and worldwide prosecution to opposition, appeal, national infringement and nullity actions and the Unified Patent Court. A technically demanding docket, complex multi-jurisdictional disputes and a quality standard maintained for decades meant any AI platform had to prove it could meet the firm where it works.
Any use of AI also had to sit within approved governance structures and meet professional, contractual, confidentiality and data-protection requirements. Solve Intelligence enables customers in Europe to process data on servers located within Europe.
Maiwald ran a fixed evaluation period in which selected functionality was assessed for approved internal use cases, after evaluating multiple solutions on the market, and then formed an enterprise partnership for 2026. Attorneys now evaluate and use Solve Intelligence in selected use cases:
The rollout is supported by Solve Intelligences Munich office and a dedicated German-speaking team of patent litigators and attorneys admitted before the UPC, the German courts and the EPO, who are building custom AI styles and templates by team, client and jurisdiction.
ChemDraw® is a registered trade mark of Revvity Signals Software, Inc.
Maiwald’s attorneys describe Solve as making AI easily accessible in the patent field and helping them evaluate large volumes of information efficiently, creating more room for strategic advice to clients.